The severe acute respiratory syndrome SARS‐CoV‐2 is the causative agent of COVID‐19.
Preventing binding of SARS‐CoV‐2 Spike glycoprotein to human ACE2 enzyme and …

To develop the drugs as a second line of preventing a serious form of illness, blocking the
interaction between a receptor‐binding domain (RBD) in the SARS‐CoV‐2 S‐protein (spike …

Background: The severe acute respiratory illness that was brought on because of the
outbreak of COVID-19 caused by the SARS-CoV-2 infection has been designated as a …

Background: In the last years, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) caused more than 760 million infections and 6.9 million deaths. Currently, remains a …

A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
spread worldwide and become pandemic with thousands new deaths and infected cases …

The aim of the present docking study was to explore the putative role of boronic moieties in
molecules interacting on the binding site of the SARS-CoV-2 main protease. The …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects the host cells
through interaction of its spike protein with human angiotensin-converting enzyme 2 (hACE …

Historically, plants have been sought after as bio-factories for the production of diverse
chemical compounds that offer a multitude of possibilities to cure diseases. To combat the …

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a fast-spreading
viral pathogen and poses a serious threat to human health. New SARS-CoV-2 variants have …

Abstract Coronavirus Disease 2019 (COVID-19), a life-threatening viral disease affected first
in china and quickly spread throughout the world in early 2020. So many scientists are …